Replies to post #191431 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Senti, I made a mistake in post 191431. I hope you did not read it. My lack of focus. You were right. The difference in survival between 24 months and 36 months for Met- patients is 21.1% (from 32.1% to 11% survival). I lost focus that from any point be it 12 or 24 months, all survivors are regarded as starting from 100% survival and the distance from 32.1% to 11% is the same as from 100% survival to 78.9% survival. (21.1%). Hence 18 met- (not 8) survived at 36 months.